Tirzepatide is a medication that works on two important hormone pathways in the body: GLP-1 and GIP. These hormones help regulate blood sugar, slow down digestion, and affect appetite. By acting on both pathways, tirzepatide can support blood sugar control and may help reduce hunger.
Some FDA-approved versions of tirzepatide, such as Mounjaro® (for type 2 diabetes) and Zepbound® (for chronic weight management), have been studied in clinical trials. These studies showed that, when used with a healthy diet and exercise, they can improve blood sugar control and support weight management.
Compounded tirzepatide formulations are not FDA-approved. They may be prescribed by your provider when appropriate and are prepared by licensed compounding pharmacies. Because compounded medications are not reviewed by the FDA, your provider will carefully monitor your treatment to make sure it’s safe and effective for your individual needs.
Tirzepatide is given as a once-weekly injection under the skin. Your provider will tell you the right dose and teach you how to give the injection yourself. Common injection sites include the abdomen, thigh, or upper arm. It’s important to take your dose on the same day each week, with or without food, to stay consistent.
If you ever miss a dose, or if you’re unsure when to take your next injection, contact your provider for guidance.